What's new,
and who it's for.
Progress in the lab and voices from the community — the updates worth passing along, and the stories that remind us why any of this matters.
Latest
All posts →The Vaccine That Could Prevent Ovarian Cancer Before It Starts
Two vaccines are in development — one to stop recurrence, with over 50% of women alive eight years later, and one to prevent the disease entirely in BRCA carriers.
Why Ovarian Cancer Stops Responding to Chemo — And How Scientists Are Fighting Back
Four studies this month reframed drug resistance: the tumor recruits your own immune cells, signals its neighbors to spread, and weaponizes its own acidity.
ASCO 2026: The Ovarian Cancer Trial Results Reshaping Treatment Standards
A 35% reduction in the risk of death, a surprising answer about surgery timing, and a lesson in why "the tumor shrank" is not the same as "she lived longer."
Stories from our network
The people behind the mission — in their own words.
“You lose complete control of everything that you have in life.”
A routine ultrasound found a cyst; surgery revealed clear cell and high-grade serous ovarian cancer. Through debulking surgery, six cycles of chemotherapy, and a clinical trial, Sara has become a voice for self-advocacy and finding community.
Sara I. — diagnosed at 34, stage 3A ovarian cancer
Read Sara’s story on The Patient Story →“Nobody hands you a map for this. Finding people who’d already walked it changed everything for our family.”
From a caregiver
“Earlier detection is the whole game. Every dollar toward it is a dollar toward more birthdays.”
A researcher we fund